These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 5271985

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. [Effectiveness of the agents of the 2d series in treating patients with chronic destructive tuberculosis of the lungs].
    Utkin VV.
    Probl Tuberk; 1973; 51(1):12-6. PubMed ID: 4727151
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. [Therapeutic effects of secondary antitubercular agents at our hospital].
    Nakayama K, Hayashida M, Ishihara M, Ijichi F, Obata Y.
    Iryo; 1966 Mar; 20(3):257-63. PubMed ID: 5964832
    [No Abstract] [Full Text] [Related]

  • 66. Cycloserine plus ethionamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
    Ramakrishnan CV, Devadatta S, Evans C, Kamat SR, Menon NK, Radhakrishna S, Rajagopalan S, Stott H, Tripathy SP, Velu S.
    Tubercle; 1967 Jun; 48(2):114-27. PubMed ID: 6048655
    [No Abstract] [Full Text] [Related]

  • 67. [Clinical problems of resistance to secondary antitubercular agents].
    Baba H, Takahashi R, Nakai T, Torii R, Yo I.
    Iryo; 1966 Mar; 20(3):230-40. PubMed ID: 5964830
    [No Abstract] [Full Text] [Related]

  • 68. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F, Perusi O.
    G Ital Mal Torace; 1966 Mar; 20(6):365-78. PubMed ID: 5997781
    [No Abstract] [Full Text] [Related]

  • 69. [Tuberculostatics of the second order (relay drugs). Their share in combined therapy of pulmonary tuberculosis].
    Naegeli HR.
    Schweiz Med Wochenschr; 1966 Apr 16; 96(15):495-500. PubMed ID: 4293638
    [No Abstract] [Full Text] [Related]

  • 70. [Tuberculostatic drugs of the second series. (Review of literature)].
    El'nik VI.
    Klin Med (Mosk); 1966 Dec 16; 44(12):19-24. PubMed ID: 4302920
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. [Various biological tests on several groups of subjects with tuberculosis subjected respectively to monotherapy with isoniazid, viomycin, pyrazinamide, cycloserine, ethioniamide and kanamycin].
    DE SIMONI G, CATTANEO C.
    Ann Ist Carlo Forlanini; 1962 Dec 16; 22():326-65. PubMed ID: 14026068
    [No Abstract] [Full Text] [Related]

  • 73. Ethionamide, pyrazinamide and cycloserine used successfully in the treatment of chronic pulmonary tuberculosis.
    SOMNER AR, BRACE AA.
    Tubercle; 1962 Dec 16; 43():345-60. PubMed ID: 13978199
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. [Minor tuberculostatic drugs].
    Berktin K.
    Turk Tip Cemiy Mecm; 1967 Aug 16; 33(8):475-85. PubMed ID: 4300575
    [No Abstract] [Full Text] [Related]

  • 78. [ETHIONAMIDE IN ASSOCIATION WITH PYRAZINAMIDE OR CYCLOSERINE IN THE TREATMENT OF CHRONIC PULMONARY TUBERCULOSIS].
    WAGNER J.
    Gruzlica (1926); 1963 Dec 16; 31():1217-22. PubMed ID: 14107826
    [No Abstract] [Full Text] [Related]

  • 79. [Chemotherapeutic activity and diffusion properties of the second series antituberculous preparations].
    Drabkina RO, Ginzburg TS.
    Klin Med (Mosk); 1966 Dec 16; 44(12):38-43. PubMed ID: 4302345
    [No Abstract] [Full Text] [Related]

  • 80. [Experiences with antitubercular agents of the second line].
    Zierski M.
    Wien Med Wochenschr; 1966 Oct 01; 116(40):824-7. PubMed ID: 5927179
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.